Novo CEO signals M&A opportunities to strengthen drug pipeline

September 22, 2026

4

Novo CEO Mike Doustdar told CNBC that it is considering M&A opportunities as it faces growing competition in the weight-loss market.Novo CEO Mike Doustdar told CNBC that it is considering M&A opportunities as it faces growing competition in the weight-loss market.

Novo CEO signals M&A opportunities to strengthen drug pipeline

Related Articles

Moody's eyes Philippines' $100bn infrastructure boom with PhilRatings stake

Peloton is revamping its treadmills with new features in the next phase of its turnaround

McDonald’s is hosting an investor day as its U.S. business struggles. Here are 4 things to expect

Latest Articles

Moody's eyes Philippines' $100bn infrastructure boom with PhilRatings stake

Peloton is revamping its treadmills with new features in the next phase of its turnaround

McDonald’s is hosting an investor day as its U.S. business struggles. Here are 4 things to expect

Despite German State Stimulus: Machinery Industry Braces For A Catastrophic Year

The Nuclear Renaissance Disconnect: Utilities Plan Big While Stocks Lag